Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,830.58
(
0.27%
)
News Focus
News Focus

Replies to post #247 on Ionis Pharmaceuticals Inc (IONS)

Replies to #247 on Ionis Pharmaceuticals Inc (IONS)
icon url

surf1944

02/26/13 9:02 AM

#248 RE: surf1944 #247

8:03AM ISIS Pharm initiates Phase 2 study Of ISIS-CRP Rx In patients with atrial fibrillation (ISIS) 14.02 : Co announced the initiation of a Phase 2 study evaluating ISIS-CRPRx in patients with paroxysmal atrial fibrillation.